Patents by Inventor Paolo Simioni

Paolo Simioni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20220090042
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 24, 2022
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20220002702
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: September 10, 2021
    Publication date: January 6, 2022
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20210238573
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: March 26, 2021
    Publication date: August 5, 2021
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20210214704
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: March 26, 2021
    Publication date: July 15, 2021
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20200231958
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: October 1, 2019
    Publication date: July 23, 2020
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20200199564
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 25, 2020
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo SIMIONI
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20200190498
    Abstract: Disclosed are a modified FIX (Factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: December 9, 2019
    Publication date: June 18, 2020
    Applicant: uniqure biopharma B.V.
    Inventor: Paolo SIMIONI
  • Factor IX polypeptide mutant, its uses and method for its production
    Patent number: 10465180
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: November 5, 2019
    Assignee: uniQure biopharma B.V.
    Inventor: Paolo Simioni
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION
    Publication number: 20180258413
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: May 25, 2018
    Publication date: September 13, 2018
    Applicant: uniQure biopharma B.V.
    Inventor: Paolo Simioni
  • Factor IX polypeptide mutant, its uses and method for its production
    Patent number: 9982248
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: May 29, 2018
    Assignee: UNIQURE BIOPHARMA B.V.
    Inventor: Paolo Simioni
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION
    Publication number: 20170355973
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: July 14, 2017
    Publication date: December 14, 2017
    Inventor: Paolo Simioni
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION
    Publication number: 20160122740
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: December 29, 2015
    Publication date: May 5, 2016
    Inventor: Paolo Simioni
  • Factor IX polypeptide mutant, its uses and a method for its production
    Patent number: 9249405
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: February 2, 2016
    Inventor: Paolo Simioni
  • FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
    Publication number: 20110244550
    Abstract: Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
    Type: Application
    Filed: September 15, 2009
    Publication date: October 6, 2011
    Inventor: Paolo Simioni